Cargando...

Safety of aromatase inhibitors in the adjuvant setting

The third-generation aromatase inhibitors (AIs) letrozole, anastrozole, and exemestane are replacing tamoxifen as adjuvant therapy in most postmenopausal women with early breast cancer. Although AIs have demonstrated superior efficacy and better overall safety compared with tamoxifen in randomized c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Perez, Edith A.
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2007
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2001222/
https://ncbi.nlm.nih.gov/pubmed/17912638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-007-9704-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!